Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adultsM.L. Piel-Julian, L. Prudhomme, Matthieu Mahévas et al.|Journal of Thrombosis and Haemostasis|2018Cited by 138
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort studyÉlie Azoulay, Kevin Rakszawski, Muriel Picard et al.|The Lancet Haematology|2021Cited by 105
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 studyMurielle Roussel, Marguerite Vignon, Hélène Demarquette et al.|Blood|2022Cited by 25
The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in FranceGuillaume Moulis, Samuel Deshayes, Marc Michel et al.|La Revue de Médecine Interne|2024Cited by 6